• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    Sangamo Biosciences Inc. (SGMO)

    -NasdaqGS
    9.97 Down 0.19(1.87%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:10.16
    Open:10.20
    Bid:9.74 x 100
    Ask:11.10 x 500
    1y Target Est:22.00
    Beta:2.97
    Earnings Date:Jul 21 - Jul 27 (Est.)
    Day's Range:9.88 - 10.31
    52wk Range:9.39 - 19.25
    Volume:762,071
    Avg Vol (3m):844,175
    Market Cap:693.74M
    P/E (ttm):N/A
    EPS (ttm):-0.35
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    ┬╗ More Headlines for SGMO

    Comparison

    Symbol% ChgMkt Cap
    SGMODown 1.87%693.74M
    AMGNDown 1.12%116.53B
    LLYUp 1.52%91.22B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):13.80
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.54
    Quarterly EPS Est (Jun-15) :-0.13
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of engineered DNA-binding proteins as novel therapeutic products for unmet medical needs in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback